Schedule of Warrant Liability (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Sep. 06, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Fair value, modification of warrants | $ 57 | $ 29 | $ 57 |
| Fair value, change in fair value of warrant liability | $ (125) | $ (133) | |
| Warrant [Member] | |||
| Warrants outstanding, beginning balance | 265,305 | 265,305 | |
| Fair value, beginning balance | $ 242 | $ 318 | |
| Warrants outstanding, warrant modification | |||
| Fair value, modification of warrants | $ 29 | $ 57 | |
| Warrants outstanding, change in fair value of warrant liability | |||
| Fair value, change in fair value of warrant liability | $ 19 | $ (133) | |
| Warrants outstanding, exercise of warrants | (194,286,000) | ||
| Fair value, exercise of wararnts | $ (144) | ||
| Warrants outstanding, ending balance | 71,019 | 265,305 | |
| Fair value, ending balance | $ 146 | $ 242 | |
| X | ||||||||||
- Definition Class of warrant or right exercise price of warrants or rights. No definition available.
|
| X | ||||||||||
- Definition Fair Value Adjustment Of Warrants Shares No definition available.
|
| X | ||||||||||
- Definition Warrant Modification. No definition available.
|
| X | ||||||||||
- Definition Warrant modification expense. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. No definition available.
|
| X | ||||||||||
- Details
|